Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

55 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Therapeutic monitoring and variability of atazanavir in HIV-infected patients, with and without HCV coinfection, receiving boosted or unboosted regimens.
Regazzi M, Villani P, Gulminetti R, Cusato M, Brandolini M, Tinelli C, Barassi A, Maserati R, Sighinolfi L, D'Arminio Monforte A, Melzi D'Eril GV. Regazzi M, et al. Among authors: cusato m. Ther Drug Monit. 2011 Jun;33(3):303-8. doi: 10.1097/FTD.0b013e31821c2772. Ther Drug Monit. 2011. PMID: 21544015 Free article.
Lopinavir/ritonavir pharmacokinetics in HIV/HCV-coinfected patients with or without cirrhosis.
Micheli V, Regazzi M, Dickinson L, Meraviglia P, Villani P, Khoo SH, Viganò P, Cordier L, Cusato M, Duca P, Orlando G, Rizzardini G, Back DJ, Cargnel A. Micheli V, et al. Among authors: cusato m. Ther Drug Monit. 2008 Jun;30(3):306-13. doi: 10.1097/FTD.0b013e318177209e. Ther Drug Monit. 2008. PMID: 18520602 Free PMC article. Clinical Trial.
Trough concentrations of lopinavir, nelfinavir, and nevirapine with standard dosing in human immunodeficiency virus-infected pregnant women receiving 3-drug combination regimens.
Baroncelli S, Villani P, Floridia M, Pirillo MF, Galluzzo CM, Cusato M, Amici R, Pinnetti C, Sabbatini F, Molinari A, Tamburrini E, Regazzi M. Baroncelli S, et al. Among authors: cusato m. Ther Drug Monit. 2008 Oct;30(5):604-10. doi: 10.1097/FTD.0b013e3181867a6e. Ther Drug Monit. 2008. PMID: 18728627
Interindividual and intra-individual variabilities of darunavir and ritonavir plasma trough concentrations in multidrug experienced HIV patients receiving salvage regimens.
Baroncelli S, Villani P, Galluzzo CM, Cavalli A, Volpe A, Francisci D, Vivarelli A, Sozio F, Tedeschi S, Cirioni O, Sighinolfi L, Cusato M, Pirillo MF, Weimer LE, Fragola V, Parruti G, Regazzi M, Floridia M. Baroncelli S, et al. Among authors: cusato m. Ther Drug Monit. 2013 Dec;35(6):785-90. doi: 10.1097/FTD.0b013e31829ad690. Ther Drug Monit. 2013. PMID: 24061444
Pharmacokinetics of nelfinavir in HIV-1-infected pregnant and nonpregnant women.
Villani P, Floridia M, Pirillo MF, Cusato M, Tamburrini E, Cavaliere AF, Guaraldi G, Vanzini C, Molinari A, degli Antoni A, Regazzi M. Villani P, et al. Among authors: cusato m. Br J Clin Pharmacol. 2006 Sep;62(3):309-15. doi: 10.1111/j.1365-2125.2006.02669.x. Br J Clin Pharmacol. 2006. PMID: 16934047 Free PMC article.
Sex differences in nevirapine disposition in HIV-infected patients.
Regazzi M, Villani P, Seminari E, Ravasi G, Cusato M, Marubbi F, Meneghetti G, Maserati R. Regazzi M, et al. Among authors: cusato m. AIDS. 2003 Nov 7;17(16):2399-400. doi: 10.1097/00002030-200311070-00018. AIDS. 2003. PMID: 14571195 No abstract available.
Clinical pharmacokinetics of nelfinavir and its metabolite M8 in human immunodeficiency virus (HIV)-positive and HIV-hepatitis C virus-coinfected subjects.
Regazzi M, Maserati R, Villani P, Cusato M, Zucchi P, Briganti E, Roda R, Sacchelli L, Gatti F, Delle Foglie P, Nardini G, Fabris P, Mori F, Castelli P, Testa L. Regazzi M, et al. Among authors: cusato m. Antimicrob Agents Chemother. 2005 Feb;49(2):643-9. doi: 10.1128/AAC.49.2.643-649.2005. Antimicrob Agents Chemother. 2005. PMID: 15673746 Free PMC article. Clinical Trial.
55 results